gemcitabine has been researched along with clobenpropit in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, KS; Kim, YT; Lee, SH; Paik, WH; Park, JM; Ryu, JK; Song, BJ; Yoon, YB | 1 |
1 other study(ies) available for gemcitabine and clobenpropit
Article | Year |
---|---|
Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Epithelial-Mesenchymal Transition; Gemcitabine; Histamine Agonists; Histamine H3 Antagonists; Humans; Imidazoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Thiourea; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |